SECOND SUPPLEMENTAL INDENTURESecond Supplemental Indenture • September 24th, 2012 • Elan Corp PLC • Pharmaceutical preparations
Contract Type FiledSeptember 24th, 2012 Company IndustryThis Second Supplemental Indenture, dated as of September 24, 2012 (this “Supplemental Indenture”), among Elan Finance public limited company, a public limited company incorporated and registered under the laws of Ireland (together with its successors and assigns), Elan Finance Corp., a Delaware corporation (together with its successors and assigns, collectively the “Issuers”), Elan Corporation, plc (the “Company”), Elan Regulatory Holdings Limited, a limited company organized under the laws of Ireland (“Elan Regulatory”), Elan Science Five Limited, a limited company organized under the laws of Ireland (“Elan Science Five”) and Drug Delivery Systems Inc., a New York corporation (“DDSI” and, together with Elan Regulatory and Elan Science Five, the “New Note Guarantors”) and each other Note Guarantor under the Indenture referred to below, and BNY Mellon Corporate Trustee Services Limited (formerly known as BNY Corporate Trustee Services Limited), as Trustee under the Indenture referred t
FIRST SUPPLEMENTAL INDENTUREFirst Supplemental Indenture • September 24th, 2012 • Elan Corp PLC • Pharmaceutical preparations
Contract Type FiledSeptember 24th, 2012 Company IndustryThis First Supplemental Indenture, dated as of September 24, 2012 (this “Supplemental Indenture”), among Elan Finance public limited company, a public limited company incorporated and registered under the laws of Ireland (together with its successors and assigns), Elan Finance Corp., a Delaware corporation (together with its successors and assigns, collectively the “Issuers”), Elan Corporation, plc (the “Company”), Elan Regulatory Holdings Limited, a limited company organized under the laws of Ireland (“Elan Regulatory”), Elan Science Five Limited, a limited company organized under the laws of Ireland (“Elan Science Five”) and Drug Delivery Systems Inc., a New York corporation (“DDSI” and, together with Elan Regulatory and Elan Science Five, the “New Note Guarantors”) and each other Note Guarantor under the Indenture referred to below, and The Bank of New York Mellon, as Trustee under the Indenture referred to below.